OrganOx wins US Medtech Insight Award
OTIF portfolio company OrganOx has been awarded the 2019 Medtech Insight Award for ‘Best Proof-of-Value of an Innovation’.
The award is OrganOx’s first in the US and recognises the benefits of it’s normothermic perfusion technology platform to increase the use of donated organs. The Medtech Insight Awards are run annually by Pharma Intelligence, a leading, US-based market intelligence provider and consultancy, and are done so with the aim of recognising outstanding achievements across a range of activities from technological and proof of value innovations to financing, clinical trials and partnerships.
Click here for the official company press release.